ALK-Abelló A/S
ALK-B
Classement en actions
#2354
ALK-Abelló A/S is a global leader in allergy solutions, with operations... ALK-Abelló A/S is a global leader in allergy solutions, with operations spanning Europe, North America, and other international regions. The company offers a comprehensive portfolio of treatments for allergic rhinitis and allergic asthma, featuring key products such as GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX. ALK-Abelló specializes in allergy immunotherapy, providing options like injections, sublingual drops, and tablets to address a wide range of sensitivities, including those to grass, ragweed, house dust mites, Japanese cedar, various tree pollens, and certain foods. Furthermore, the company engages with consumers through a digital healthcare ecosystem, a platform designed to connect with allergy sufferers early in their journey, offering tools, e-commerce solutions, and guidance to support and streamline access to immunotherapy. ALK-Abelló also provides essential diagnostic allergy services, including skin prick and blood tests, alongside emergency treatments such as intramuscular adrenaline injections for severe, life-threatening allergic reactions like anaphylaxis. The company was established in 1923 and is based in Hørsholm, Denmark.
Prix de l'action
$37.76
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$8.38B
Changement (1 jour)
-0.08%
Changement (1 an)
14.34%
Pays
DK
Échange ALK-Abelló A/S (ALK-B)
Catégorie
Healthcare
Nombre d'actions en circulation pour ALK-Abelló A/S (ALK-B)
Nombre d'actions en circulation au June 2026: 221.88M
Selon les derniers rapports financiers et le cours de l'action de ALK-Abelló A/S, le nombre actuel d'actions en circulation est de 221.88M. À la fin de December 2023, l'entreprise avait 221.15M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de ALK-Abelló A/S (ALK-B) de 2004 à 2026
Actions en circulation à la fin de chaque année
| Année | Actions en circulation | Changez |
|---|---|---|
| 2026 (TTM) | 221.88M | 0.25% |
| 2024 | 221.32M | 0.08% |
| 2023 | 221.15M | 0.29% |
| 2022 | 220.50M | 0.51% |
| 2021 | 219.39M | 0.49% |
| 2020 | 218.32M | 0.14% |
| 2019 | 218.01M | 0.31% |
| 2018 | 217.33M | 9.53% |
| 2017 | 198.43M | 1.07% |
| 2016 | 196.33M | 1.15% |
| 2015 | 194.09M | 0.46% |
| 2014 | 193.20M | 0.00% |
| 2013 | 193.20M | -0.87% |
| 2012 | 194.91M | -1.53% |
| 2011 | 197.94M | -0.14% |
| 2010 | 198.22M | -0.49% |
| 2009 | 199.19M | -0.34% |
| 2008 | 199.88M | -0.33% |
| 2007 | 200.53M | -0.74% |
| 2006 | 202.02M | 0.47% |
| 2005 | 201.07M | -0.60% |
| 2004 | 202.28M | 0.00% |
Actions en circulation pour des entreprises similaires ou concurrentes
| Entreprise | Actions en circulation | Différence | Pays |
|---|---|---|---|
| 253.90M | 14.43% |
US
|
|
| 396.00M | 78.48% |
US
|
|
| 478.91M | 115.84% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -71.97% |
NL
|
